Author

O. Puig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. de Dios· 1 shared C. Baquero· 1 shared C. Marugan· 1 shared C. Mur· 1 shared H. Bian· 1 shared J. Du· 1 shared M. J. Lallena· 1 shared M. P. Ganado· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. de Dios

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Efficient inhibition of cell proliferation and promotion of apoptosis requires continuous treatment with abemaciclib.

R. Torres-Guzman, M. P. Ganado, C. Mur, C. Marugan, C. Baquero, Y. Yang, Y. Zeng, H. Bian, J. Du, A. de Dios, O. Puig, M. J. Lallena

This study shows abemaciclib, a CDK4/6 inhibitor, effectively inhibits cell proliferation and induces apoptosis with continuous treatment, outperforming other CDK4/6 inhibitors in breast cancer cell lines.

bioRxiv · Nov 15, 2021 · PreprintCell Biology